Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities.
cabozantinib
differentiated thyroid cancer
lenvatinib
medullary thyroid cancer
pralsetinib
selpercatinib
sorafenib
targeted therapy
tyrosine kinase inhibitors
vandetanib
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Mar 2021
18 Mar 2021
Historique:
received:
10
02
2021
revised:
09
03
2021
accepted:
10
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
22
4
2021
Statut:
epublish
Résumé
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only treated with surgery but only intrathyroidal tumors are cured. The worst prognosis is for anaplastic (ATC) and poorly differentiated thyroid cancer (PDTC). Whenever a local or metastatic advanced disease is present, other treatments are required, varying from local to systemic therapies. In the last decade, the efficacy of the targeted therapies and, in particular, tyrosine kinase inhibitors (TKIs) has been demonstrated. They can prolong the disease progression-free survival and represent the most important therapeutic option for the treatment of advanced and progressive thyroid cancer. Currently, lenvatinib and sorafenib are the approved drugs for the treatment of RAI-refractory DTC and PDTC while advanced MTC can be treated with either cabozantinib or vandetanib. Dabrafenib plus trametinib is the only approved treatment by FDA for
Identifiants
pubmed: 33803747
pii: ijms22063117
doi: 10.3390/ijms22063117
pmc: PMC8003273
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Associazione Italiana Ricerca sul Cancro
ID : Grant 2018, Project code 21790
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : PRIN 2017, protocol 2017YTWKWH
Références
Thyroid. 2018 Jan;28(1):72-78
pubmed: 29048237
Curr Genomics. 2011 Dec;12(8):618-25
pubmed: 22654561
Oncogene. 2004 Aug 12;23(36):6056-63
pubmed: 15184865
Cell. 2014 Oct 23;159(3):676-90
pubmed: 25417114
Mol Diagn Ther. 2018 Feb;22(1):41-56
pubmed: 28986854
Eur J Cancer. 2019 Sep;118:35-40
pubmed: 31299580
J Clin Invest. 2011 Dec;121(12):4700-11
pubmed: 22105174
Clin Cancer Res. 2021 Apr 15;27(8):2130-2135
pubmed: 33239432
iScience. 2019 Oct 25;20:324-336
pubmed: 31605946
J Clin Endocrinol Metab. 2018 Oct 1;103(10):3698-3705
pubmed: 30032208
Thyroid. 2018 Feb;28(2):158-167
pubmed: 29281951
Oncogene. 2016 Apr 21;35(16):2123-32
pubmed: 26212008
Korean J Radiol. 2014 Nov-Dec;15(6):817-26
pubmed: 25469095
Cancer. 2015 Aug 15;121(16):2749-56
pubmed: 25913680
Clin Cancer Res. 2023 Aug 18;:
pubmed: 37594724
Cancer. 2006 Mar 15;106(6):1286-95
pubmed: 16470605
Mol Cell Endocrinol. 2013 Sep 5;377(1-2):1-6
pubmed: 23811235
Endocr Relat Cancer. 2019 Dec 1;27(2):97-110
pubmed: 31804969
J Clin Endocrinol Metab. 2001 Apr;86(4):1568-73
pubmed: 11297585
Front Endocrinol (Lausanne). 2020 Mar 13;11:102
pubmed: 32231639
J Cancer Epidemiol. 2013;2013:965212
pubmed: 23737785
Cancer. 2017 Feb 1;123(3):372-381
pubmed: 27741354
Nat Rev Cancer. 2013 Mar;13(3):184-99
pubmed: 23429735
Thyroid. 2019 Nov;29(11):1615-1622
pubmed: 31595822
Clin Cancer Res. 2015 Mar 1;21(5):1028-35
pubmed: 25549723
Thyroid. 2014 Sep;24(9):1369-74
pubmed: 24798894
Nat Med. 2013 Nov;19(11):1423-37
pubmed: 24202395
AJR Am J Roentgenol. 2002 Mar;178(3):699-704
pubmed: 11856701
Minerva Endocrinol. 2008 Dec;33(4):341-57
pubmed: 18923370
J Clin Endocrinol Metab. 2017 Dec 1;102(12):4506-4514
pubmed: 29029287
Lancet Oncol. 2020 Feb;21(2):271-282
pubmed: 31838007
Front Endocrinol (Lausanne). 2012 Feb 29;3:31
pubmed: 22645520
Thyroid. 2012 Nov;22(11):1104-39
pubmed: 23130564
J Clin Oncol. 2012 Jan 10;30(2):134-41
pubmed: 22025146
J Clin Endocrinol Metab. 2019 May 1;104(5):1417-1428
pubmed: 30256977
Lancet Oncol. 2016 Sep;17(9):1272-82
pubmed: 27460442
Thyroid. 2012 Sep;22(9):905-10
pubmed: 22870901
Thyroid. 2013 Aug;23(8):997-1002
pubmed: 23311700
Clin Cancer Res. 2013 Aug 1;19(15):4239-48
pubmed: 23766359
Cancers (Basel). 2019 Sep 02;11(9):
pubmed: 31480712
J Nucl Med. 1996 Apr;37(4):598-605
pubmed: 8691248
Crit Rev Clin Lab Sci. 2017 May;54(3):205-218
pubmed: 28393575
Nat Rev Endocrinol. 2020 Nov;16(11):629-641
pubmed: 32839578
Eur J Cancer. 2017 Apr;75:213-221
pubmed: 28237867
Endocrine. 2013 Aug;44(1):172-81
pubmed: 23264145
Thyroid. 2021 Feb;31(2):224-232
pubmed: 32907501
Cell. 2006 Jan 27;124(2):263-6
pubmed: 16439202
J Endocrinol Invest. 2021 Jan;44(1):95-103
pubmed: 32363491
J Clin Oncol. 2013 Oct 10;31(29):3639-46
pubmed: 24002501
Cancer Discov. 2018 Jul;8(7):836-849
pubmed: 29657135
World J Gastroenterol. 2016 Apr 21;22(15):3885-91
pubmed: 27099433
Eur Radiol. 2003 Jan;13(1):136-40
pubmed: 12541121
J Cancer. 2020 Jun 8;11(16):4884-4896
pubmed: 32626535
J Clin Oncol. 2017 Oct 10;35(29):3315-3321
pubmed: 28817373
J Clin Oncol. 2020 Aug 10;38(23):2620-2627
pubmed: 32364844
J Clin Endocrinol Metab. 2008 Aug;93(8):3106-16
pubmed: 18492751
BMC Cancer. 2019 Mar 4;19(1):196
pubmed: 30832606
Thyroid. 2014 Oct;24(10):1508-14
pubmed: 25102375
Genes (Basel). 2019 Sep 13;10(9):
pubmed: 31540307
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
Cancers (Basel). 2020 Feb 07;12(2):
pubmed: 32046148
Oral Oncol. 2018 Dec;87:158-164
pubmed: 30527232
Cancer Res. 2011 Jul 1;71(13):4403-11
pubmed: 21596819
Eur Thyroid J. 2012 Apr;1(1):5-14
pubmed: 24782992
J Clin Oncol. 2009 Apr 1;27(10):1675-84
pubmed: 19255327
N Engl J Med. 2015 Aug 20;373(8):726-36
pubmed: 26287849
Best Pract Res Clin Endocrinol Metab. 2017 Jun;31(3):349-361
pubmed: 28911730
Clin Endocrinol (Oxf). 2006 Jun;64(6):617-24
pubmed: 16712662
Ann Surg Oncol. 2021 Mar;28(3):1731-1739
pubmed: 32808161
Med Oncol. 2019 Jan 21;36(2):19
pubmed: 30666498
Thyroid Res. 2009 Aug 01;2(1):8
pubmed: 19646277
Mol Cell Endocrinol. 2010 May 28;321(1):44-9
pubmed: 19883730
Cancers (Basel). 2020 Dec 11;12(12):
pubmed: 33322354
Endocr Relat Cancer. 2016 Mar;23(3):R143-55
pubmed: 26733501
Thyroid. 2013 May;23(5):600-4
pubmed: 23113752
Ann Oncol. 2017 Nov 01;28(11):2813-2819
pubmed: 29045520
Endocrinol Metab Clin North Am. 2008 Jun;37(2):375-87, viii-ix
pubmed: 18502332
ESMO Open. 2016 Mar 18;1(2):e000023
pubmed: 27843590
J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9
pubmed: 16684830
J Clin Endocrinol Metab. 2010 May;95(5):2325-33
pubmed: 20207826
Endocr Relat Cancer. 2017 Feb;24(2):97-106
pubmed: 28093480
Lancet. 2014 Jul 26;384(9940):319-28
pubmed: 24768112
J Hematol Oncol. 2016 Oct 4;9(1):105
pubmed: 27716285
N Engl J Med. 2015 Feb 12;372(7):621-30
pubmed: 25671254
J Endocrinol Invest. 2017 Jan;40(1):55-62
pubmed: 27535135
Cancer. 2017 Nov 1;123(21):4114-4121
pubmed: 28662274
Surgery. 2001 Dec;130(6):971-7
pubmed: 11742325
Front Endocrinol (Lausanne). 2017 Oct 16;8:273
pubmed: 29085338
Cancer Res. 2009 Jun 1;69(11):4885-93
pubmed: 19487299
Am J Surg Pathol. 2007 Aug;31(8):1256-64
pubmed: 17667551
Cancer Cell. 2018 Aug 13;34(2):256-270.e5
pubmed: 30107176
J Clin Oncol. 2018 Jan 1;36(1):7-13
pubmed: 29072975
Nature. 2013 Sep 19;501(7467):355-64
pubmed: 24048068
Endocrine. 2021 Feb;71(2):434-442
pubmed: 32691271
Eur J Endocrinol. 2016 Sep;175(3):173-80
pubmed: 27283290
Cancer. 2018 Jun 1;124(11):2365-2372
pubmed: 29656442
Mol Cancer. 2018 Feb 19;17(1):58
pubmed: 29455648
Ann Surg. 2007 Sep;246(3):466-70; discussion 470-1
pubmed: 17717450
J Endocrinol Invest. 2003;26(8 Suppl):72-4
pubmed: 15233217
Genes (Basel). 2020 Apr 15;11(4):
pubmed: 32326537
FASEB J. 2015 Feb;29(2):623-35
pubmed: 25384422
Nat Rev Endocrinol. 2017 Nov;13(11):644-660
pubmed: 28707679
N Engl J Med. 2013 Feb 14;368(7):623-32
pubmed: 23406027
Int J Mol Sci. 2017 Jun 21;18(6):
pubmed: 28635633
Endocr Relat Cancer. 2019 Jan 1;26(1):153-164
pubmed: 30139768
Thyroid. 2015 Jun;25(6):567-610
pubmed: 25810047
N Engl J Med. 2020 Oct 22;383(17):1686-1687
pubmed: 33085869
Nat Rev Clin Oncol. 2018 Dec;15(12):731-747
pubmed: 30333516
J Clin Oncol. 2008 Oct 10;26(29):4714-9
pubmed: 18541894
Nat Rev Endocrinol. 2014 Oct;10(10):616-23
pubmed: 25069464
Front Endocrinol (Lausanne). 2020 Sep 02;11:599
pubmed: 32982983
Thyroid. 2009 Mar;19(3):233-40
pubmed: 19265494
Therap Adv Gastroenterol. 2016 Mar;9(2):240-9
pubmed: 26929785
Lancet Oncol. 2020 Apr;21(4):531-540
pubmed: 32105622
J Clin Endocrinol Metab. 2008 Oct;93(10):3943-9
pubmed: 18682506
N Engl J Med. 2020 Aug 27;383(9):825-835
pubmed: 32846061
Cancer. 2014 Jul 1;120(13):1920-31
pubmed: 24699901
Thyroid. 2013 Jan;23(1):50-7
pubmed: 23240926
Eur Arch Otorhinolaryngol. 2017 Sep;274(9):3497-3501
pubmed: 28664330
J Clin Endocrinol Metab. 2013 May;98(5):E811-9
pubmed: 23526464
Am J Clin Pathol. 2015 Jun;143(6):768-77
pubmed: 25972318
J Clin Endocrinol Metab. 2003 Jul;88(7):3184-9
pubmed: 12843163
Endocr Relat Cancer. 2018 May;25(5):523-531
pubmed: 29507047
J Clin Endocrinol Metab. 2006 Jan;91(1):313-9
pubmed: 16263822
J Clin Endocrinol Metab. 2001 Mar;86(3):1346-54
pubmed: 11238531
Mayo Clin Proc. 1992 Oct;67(10):934-40
pubmed: 1434853
Semin Nucl Med. 2016 May;46(3):215-24
pubmed: 27067502